IN2014CN03925A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN03925A IN2014CN03925A IN3925CHN2014A IN2014CN03925A IN 2014CN03925 A IN2014CN03925 A IN 2014CN03925A IN 3925CHN2014 A IN3925CHN2014 A IN 3925CHN2014A IN 2014CN03925 A IN2014CN03925 A IN 2014CN03925A
- Authority
- IN
- India
- Prior art keywords
- chimeric protein
- dengue virus
- create
- virus
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550982P | 2011-10-25 | 2011-10-25 | |
| PCT/US2012/061893 WO2013063248A1 (en) | 2011-10-25 | 2012-10-25 | Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03925A true IN2014CN03925A (https=) | 2015-07-03 |
Family
ID=48168485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3925CHN2014 IN2014CN03925A (https=) | 2011-10-25 | 2012-10-25 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150265694A1 (https=) |
| EP (1) | EP2771366A4 (https=) |
| CN (1) | CN104736568A (https=) |
| BR (1) | BR112014009887A2 (https=) |
| CR (1) | CR20140189S (https=) |
| HK (2) | HK1198770A1 (https=) |
| IN (1) | IN2014CN03925A (https=) |
| PH (1) | PH12014500911A1 (https=) |
| SG (1) | SG11201401733VA (https=) |
| WO (1) | WO2013063248A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181258B1 (ko) | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US9969986B2 (en) | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| KR102532832B1 (ko) * | 2014-09-11 | 2023-05-16 | 브이엘피 테라퓨틱스 인코포레이티드 | 플라비바이러스 바이러스 유사 입자 |
| JP2019511533A (ja) * | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| CN105732777B (zh) * | 2016-05-05 | 2019-06-04 | 中国人民解放军军事医学科学院微生物流行病研究所 | 黄热病毒特异性检测抗原及其应用 |
| EP3621645A4 (en) | 2017-05-10 | 2021-01-27 | University of Massachusetts | BIVALENT VACCINES AGAINST DENGUE / HEPATITIS B |
| SG11202005792RA (en) | 2017-12-20 | 2020-07-29 | Vlp Therapeutics Llc | Alphavirus replicon particle |
| CN113429479B (zh) * | 2018-04-04 | 2023-03-10 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
| CN109627294B (zh) * | 2018-12-29 | 2020-10-09 | 四川大学 | 一种正确折叠的重组狂犬病毒g蛋白胞外段及其潜在应用 |
| TWI891771B (zh) | 2020-04-17 | 2025-08-01 | 美商Ｖｌｐ醫療股份有限公司 | 冠狀病毒疫苗 |
| AU2021264216A1 (en) | 2020-04-30 | 2022-11-10 | Vlp Therapeutics, Inc. | Cytokine immunotherapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| CN1551782A (zh) * | 2001-06-01 | 2004-12-01 | ��������ķ������ | 嵌合黄病毒载体 |
| ZA200802176B (en) * | 2005-08-10 | 2009-08-26 | Acambis Inc | Vaccination against dengue virus infection |
-
2012
- 2012-10-25 SG SG11201401733VA patent/SG11201401733VA/en unknown
- 2012-10-25 IN IN3925CHN2014 patent/IN2014CN03925A/en unknown
- 2012-10-25 CN CN201280052904.8A patent/CN104736568A/zh active Pending
- 2012-10-25 HK HK14112282.6A patent/HK1198770A1/xx unknown
- 2012-10-25 HK HK15106951.7A patent/HK1206366A1/xx unknown
- 2012-10-25 BR BR112014009887A patent/BR112014009887A2/pt not_active IP Right Cessation
- 2012-10-25 WO PCT/US2012/061893 patent/WO2013063248A1/en not_active Ceased
- 2012-10-25 PH PH1/2014/500911A patent/PH12014500911A1/en unknown
- 2012-10-25 US US13/660,653 patent/US20150265694A1/en not_active Abandoned
- 2012-10-25 EP EP12842872.9A patent/EP2771366A4/en not_active Withdrawn
-
2014
- 2014-04-25 CR CR20140189F patent/CR20140189S/es unknown
-
2017
- 2017-01-23 US US15/413,347 patent/US10124053B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2771366A4 (en) | 2015-06-03 |
| BR112014009887A2 (pt) | 2017-04-25 |
| PH12014500911A1 (en) | 2014-06-09 |
| CN104736568A (zh) | 2015-06-24 |
| SG11201401733VA (en) | 2014-09-26 |
| US10124053B2 (en) | 2018-11-13 |
| US20170202945A1 (en) | 2017-07-20 |
| CR20140189S (es) | 2014-09-24 |
| US20150265694A1 (en) | 2015-09-24 |
| EP2771366A1 (en) | 2014-09-03 |
| HK1206366A1 (en) | 2016-01-08 |
| WO2013063248A1 (en) | 2013-05-02 |
| HK1198770A1 (en) | 2015-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03925A (https=) | ||
| PH12013502621A1 (en) | Vaccine composition comprising an inactivated chikungunya virus strain | |
| MD20140035A2 (ro) | Metodă de tratament al hepatitei virale C | |
| TN2015000185A1 (en) | 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group | |
| MX2011011331A (es) | Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas. | |
| TN2013000485A1 (en) | 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group | |
| EA201270616A1 (ru) | Ингибиторы вируса гепатита с | |
| PH12013501683A1 (en) | Yeast-based therapeutic for chronic hepatitis b infection | |
| MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
| IN2014CN03113A (https=) | ||
| PH12014502628A1 (en) | Compositions and methods related to the prevention and treatment of rabies infection | |
| MX387396B (es) | Un poliepitope quimerico de virus de dengue compuesto por fragmentos de proteinas no estructurales y su uso en una composicion inmunogenica contra infeccion de virus de dengue. | |
| PH12015502230A1 (en) | Novel viral replication inhibitors | |
| PH12013502177A1 (en) | Hepatitis c virus inhibitors | |
| TN2015000186A1 (en) | N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group | |
| CL2012000783A1 (es) | Proceso para mejorar la eficacia de proteccion metodo para inducir una respuesta inmune contra el virus del dengue que comprende vacunas de dna y virus quimericos 17d; composicion vacunal que comprende vacunas de dna contra los cuatro serotipos del virus dengue y virus quimericos comprendiendo el virus vacunal de fiebre amarilla; plasmido recombinante conteniendo el gen de la proteína e. | |
| WO2014201027A3 (en) | Treatment of merkel cell polyomavirus infection | |
| BR112013007308A2 (pt) | vacina | |
| MY164064A (en) | Anti-viral compounds | |
| MX358496B (es) | Terapeuticos a base de levadura para infeccion de la hepatitis b cronica. | |
| UA67522U (ru) | Способ повышения чувствительности к цефатоксиму музейного штамма золотистого стафилококка атсс 25923 |